DK593389D0 - Inhibitorer af dopamin-beta-hydroxylase og fremgangsmaader til fremstilling deraf samt deres anvendelse - Google Patents

Inhibitorer af dopamin-beta-hydroxylase og fremgangsmaader til fremstilling deraf samt deres anvendelse

Info

Publication number
DK593389D0
DK593389D0 DK593389A DK593389A DK593389D0 DK 593389 D0 DK593389 D0 DK 593389D0 DK 593389 A DK593389 A DK 593389A DK 593389 A DK593389 A DK 593389A DK 593389 D0 DK593389 D0 DK 593389D0
Authority
DK
Denmark
Prior art keywords
dopamine
beta
procedures
preparation
hydroxylase inhibitors
Prior art date
Application number
DK593389A
Other languages
English (en)
Other versions
DK593389A (da
Inventor
Lawrence Ivan Kruse
Stephen Torey Ross
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of DK593389D0 publication Critical patent/DK593389D0/da
Publication of DK593389A publication Critical patent/DK593389A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/16—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DK593389A 1988-12-01 1989-11-24 Inhibitorer af dopamin-beta-hydroxylase og fremgangsmaader til fremstilling deraf samt deres anvendelse DK593389A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27863788A 1988-12-01 1988-12-01

Publications (2)

Publication Number Publication Date
DK593389D0 true DK593389D0 (da) 1989-11-24
DK593389A DK593389A (da) 1990-06-02

Family

ID=23065756

Family Applications (1)

Application Number Title Priority Date Filing Date
DK593389A DK593389A (da) 1988-12-01 1989-11-24 Inhibitorer af dopamin-beta-hydroxylase og fremgangsmaader til fremstilling deraf samt deres anvendelse

Country Status (6)

Country Link
EP (1) EP0371733A3 (da)
JP (1) JPH02193985A (da)
AU (1) AU4551889A (da)
CA (1) CA2002245A1 (da)
DK (1) DK593389A (da)
PT (1) PT92475A (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63239277A (ja) * 1988-01-07 1988-10-05 Fujisawa Pharmaceut Co Ltd チアゾール酢酸誘導体
HU205092B (en) * 1989-11-24 1992-03-30 Richter Gedeon Vegyeszet Process for producing new thiazolidinone derivatives and pharmaceutical compositions comprising same
US5438150A (en) * 1994-04-26 1995-08-01 Syntex (U.S.A.) Inc. Process for making 1-benzocycloalkyl-1,3-dihydroimidazole-2-thione derivatives
US5538988A (en) * 1994-04-26 1996-07-23 Martinez; Gregory R. Benzocycloalkylazolethione derivatives
US7414137B2 (en) * 2006-03-23 2008-08-19 Inspire Pharmaceuticals, Inc. Process for the preparation of 3,4-disubstituted-thiazolidin-2-ones

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3215703A (en) * 1962-02-28 1965-11-02 American Cyanamid Co Certain bis-2-thiazolidinethiones
US4743613A (en) * 1986-04-08 1988-05-10 Smithkline Beckman Corporation Ester prodrugs of dopamine-β-hydroxylase, inhibitors, composition containing them, and method of using them to inhibit dopamine-β-hydroxylase activity

Also Published As

Publication number Publication date
PT92475A (pt) 1990-06-29
AU4551889A (en) 1990-06-07
CA2002245A1 (en) 1990-06-01
EP0371733A2 (en) 1990-06-06
EP0371733A3 (en) 1990-11-14
JPH02193985A (ja) 1990-07-31
DK593389A (da) 1990-06-02

Similar Documents

Publication Publication Date Title
DK543189A (da) Lysyloxidaseinhibitorer og deres anvendelse
DK320386D0 (da) I monolag fordelte krystallinske blandede methalhydroxidforbindelser og fremgangsmaade til fremstilling deraf samt deres anvendelse
DK316189D0 (da) Heteroaryloxy-n-isopropylanilider, fremgangsmaade til deres fremstilling samt deres anvendelse
DK39885A (da) Paaviselige molekyler samt fremgangsmaade til deres fremstilling og anvendelse
DK120188D0 (da) Aminomethylheterocycler, fremgangsmaader til deres fremstilling samt deres anvendelse
DK454188D0 (da) 2-oxo-1-sulfonylaminocarbonyl-azetidiner samt fremgangsmaade til deres fremstilling
DK397388A (da) Derivater af n-aminobutyl-n-phenylarylamider til terapeutisk anvendelse samt fremgangsmaade til fremstilling af saadanne derivater
DK381689D0 (da) Fremgangsmaade til konservering af ophthalmiske oploesninger og midler til anvendelse derved
DK661288D0 (da) Iminophenylthiazolidiner, fremgangsmaade til deres fremstilling samt anvendelsen heraf
DK393382A (da) Aminoorganoaminosilaner, fremgangsmaade til fremstilling heraf samt deres anvendelse
DK515786A (da) Inhibitorer for dopamin-beta-hydroxylase samt fremgangsmaade til fremstilling heraf
DK115288A (da) Pesticid anvendelse af 2-phenylimidazolderivater samt 2-phenyl-imidazolderivater og fremgangsmaader til deres fremstilling
DK593389A (da) Inhibitorer af dopamin-beta-hydroxylase og fremgangsmaader til fremstilling deraf samt deres anvendelse
DK178589A (da) Triazoloaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK164785C (da) 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner, deres fremstilling og deres anvendelse til fremstilling af antipedressive midler
DK239385A (da) Krystallinske metallophosphoaluminater samt fremgangsmaade til fremstilling og anvendelse af disse
DK593589A (da) Inhibitorer af dopamin-beta-hydroxylase og fremgangsmaade til fremstilling deraf samt deres anvendelse
DK219985A (da) Fremgangsmaade til fremstilling af kiselsyrerige poroese formlegemer samt deres anvendelse
DK440688A (da) Sulfonylaminoguanidinoaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK259089A (da) Aminoguanidinoaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK630788D0 (da) N-substituerede dichlormaleinimider, fremgangsmaade til deres fremstiling samt deres anvendelse
DK62086A (da) Dopamin-beta-hydroxylase inhibitorer og fremgangsmaade til fremstilling deraf samt midler indeholdende inhibitorerne
DK239485A (da) Krystallinsk ferrophosphoaluminat samt fremgangsmaade til fremstilling og anvendelse af dette
DK161124C (da) Fremgangsmaade og vaerktoej til koldtryksvejsning samt anvendelse af fremgangsmaaden
DK264788D0 (da) Azolyl-tetrahydrofuran-2-yliden-methaner, fremgangsmaader til deres fremstilling samt deres anvendelse